Economic analysis alongside clinical trials. Revisiting the methodological issues.
about
Dressings for venous leg ulcers: systematic review and meta-analysisIs complementary and alternative medicine (CAM) cost-effective? A systematic review.Multimorbidity in chronic disease: impact on health care resources and costsBringing in health technology assessment and cost-effectiveness considerations at an early stage of drug developmentPharmacoeconomic analysis of cefmenoxime dual individualization in the treatment of nosocomial pneumoniaCost effectiveness of peginterferon alpha-2b plus ribavirin versus interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C.Introduction of the flash-lamp pulsed-dye laser treatment of facial port-wine stains in childhood: A case of health care technology assessment.Analysis and interpretation of cost data in randomised controlled trials: review of published studies.Experimental versus observational data in the economic evaluation of pharmaceuticals.Feasibility of using administrative claims data for cost-effectiveness analysis of a clinical trialClinical needs for hematopoietic growth factors: old and new.Pharmacoeconomic evaluation of new treatments: efficacy versus effectiveness studies?Development of WHO guidelines on generalized cost-effectiveness analysis.Cost-effectiveness analysis in Parkinson's disease: determining the value of interventions.Understanding quality-adjusted life years and their application to pharmacoeconomic research.Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. TERMPROM Study Group. Term Prelabour Rupture of the Membranes.Use of an angular transformation for ratio estimation in cost-effectiveness analysis.'More than just money' -- widening the understanding of the costs involved in cancer care.Introducing economic and quality of life measurements into clinical studies.An introduction to economic evaluation of health care.Prenatal screening for cystic fibrosis carriers: an economic evaluationNutrition economics - characterising the economic and health impact of nutrition.Randomized controlled trials in schizophrenia: a critical perspective on the literature.Assessing the effectiveness of health interventions for cost-effectiveness analysis. Panel on Cost-Effectiveness in Health and MedicineEconomic analysis of complementary, alternative, and integrative medicine: considerations raised by an expert panel.Some guidelines on the use of cost effectiveness league tables.Randomised controlled trial and economic evaluation of podophyllotoxin solution, podophyllotoxin cream, and podophyllin in the treatment of genital warts.An introduction to the basic principles of health economics for those involved in the development and delivery of headache care.Health economics and quality of life in cancer trials: report based on a UKCCCR workshop. United Kingdom Coordinating Committee on Cancer ResearchFollow-up of breast cancer in primary care vs specialist care: results of an economic evaluation.Cost-effectiveness of interventions for children with speech, language and communication needs (SLCN): a review using the Drummond and Jefferson (1996) 'Referee's Checklist'Evaluating the economics of complementary and integrative medicineQuality assessment of economic analyses of pharmacological and nutritional therapy for hyperlipidemia.Generalizing costs from trials. Analyzing center selection bias in a breast screening trial.Efficient Research Design: Using Value-of-Information Analysis to Estimate the Optimal Mix of Top-down and Bottom-up Costing Approaches in an Economic Evaluation alongside a Clinical Trial.Economic evaluation and health care. What does it mean?Economic analysis in phase III clinical cancer trials.Evaluation of pharmacoeconomic studies: utilization of a checklist.Trials and tribulations. Emerging issues in designing economic evaluations alongside clinical trials.The use of condition specific outcome measures in economic appraisal.
P2860
Q24682142-24C9DCD2-BAF7-42CE-A903-BE9DC0FD99FBQ24816198-E2EB12B3-F358-4F83-9807-8000B34DB08FQ26741437-A8825168-828E-4389-8B75-12D4BF31C3A7Q26866095-4B9FD385-FE70-48F5-80D0-3A3FD51EF639Q28254231-44D1F152-5DDF-44F2-AC80-76669FFFE9EEQ30444892-7380F03A-30A6-4802-830C-D55F9AEAA008Q30657685-D553BCE3-E566-4A35-9C93-3E3D8EB4BB02Q31987799-E6A99497-3B7B-4ED3-9F86-095515B729EBQ32065850-19D4EE35-4824-47DE-8CB2-2C19C869CC3AQ33446356-EFBBA63D-96F2-488F-BB2E-60A180DEEC57Q33497903-EFEC896A-99A9-43D7-B38F-3C345F6C1B8DQ33782365-6A65EF72-B050-41A1-B270-378B7E1A5268Q33903387-0183D4C9-F327-4461-BA95-1D259793384DQ33929699-1DB6E3D2-B7A3-422A-A4B6-DF92FC2CBC17Q33992542-45314C1F-96A2-4123-989A-93D92C8E5AE7Q34026676-FA3F74E6-17FB-4398-AAA0-7BA3E1EFE6C6Q34066748-CA364C6C-37CA-48A6-9036-E65E10BE63ACQ34184814-B8AE7F2E-C560-4EA9-8D7F-626281FD7D24Q34329579-62A2D891-8ADE-44D9-8D73-1AB155E572B8Q34337037-A9F450B5-57A4-4CF2-B00D-A963D0D3A0CDQ34387326-BFA75E7D-70C4-4696-9CE7-E3515ABA59C8Q34501500-F1DEF6FE-F582-4047-836B-E73DB57F6569Q34593814-994DB110-FCCD-4FF5-A102-3D102394F40EQ34753553-B248B66F-C189-4099-8267-07399CD42C26Q34865294-5100EA3F-B999-4B2E-8AB5-5D25DBADE499Q35187239-D7994359-3C94-48B1-96D1-529111C94BF7Q35530839-5F5ADB26-D09C-43BF-8C20-A45461F5BC8CQ36234262-BDB5B63D-D362-4464-9D3F-30602A4C2F16Q36292071-1771C133-FB09-44FA-881F-7D7106240645Q36617493-F55F36B7-89F2-496D-88F9-39517871A062Q36768553-1A4E36FF-E342-4AE2-9C85-21E6B16084CEQ37323925-5BB1B214-DA24-48A6-B433-AF62B6B70747Q37609307-1081C2E7-8C81-4EAE-84CD-F0A0BC78690EQ39477523-AB4326B8-0C0F-449D-B876-0B89538C07FCQ40112592-7104A2A1-4BF2-4755-B73E-D32F4CDB73EDQ40423377-C9FDE552-1EE7-4E41-971F-38770D4AAD2BQ40754417-FE0D7D2A-C643-4EEC-A7ED-2DDBBDEF1B41Q40771029-A4B92BA9-112D-4BD6-AF77-70A0F5162317Q40866233-8C315C85-EADA-43D4-8416-CD991DB95465Q40926984-6972EFA7-4B28-41CF-B6AE-22BBC5B905D3
P2860
Economic analysis alongside clinical trials. Revisiting the methodological issues.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
Economic analysis alongside clinical trials. Revisiting the methodological issues.
@en
Economic analysis alongside clinical trials. Revisiting the methodological issues.
@nl
type
label
Economic analysis alongside clinical trials. Revisiting the methodological issues.
@en
Economic analysis alongside clinical trials. Revisiting the methodological issues.
@nl
prefLabel
Economic analysis alongside clinical trials. Revisiting the methodological issues.
@en
Economic analysis alongside clinical trials. Revisiting the methodological issues.
@nl
P2860
P1476
Economic analysis alongside clinical trials. Revisiting the methodological issues.
@en
P2093
P2860
P304
P356
10.1017/S0266462300007121
P577
1991-01-01T00:00:00Z